Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arrowhead Pharmaceuticals (ARWR) Interest Coverage Ratio (2022 - 2025)

Arrowhead Pharmaceuticals (ARWR) has disclosed Interest Coverage Ratio for 4 consecutive years, with 1.81 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Coverage Ratio rose 124.32% year-over-year to 1.81, compared with a TTM value of 3.33 through Dec 2025, up 125.88%, and an annual FY2025 reading of 1.1, up 105.92% over the prior year.
  • Interest Coverage Ratio was 1.81 for Q4 2025 at Arrowhead Pharmaceuticals, down from 2.03 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 17.62 in Q1 2025 and bottomed at 34.58 in Q2 2024.
  • Average Interest Coverage Ratio over 4 years is 9.77, with a median of 11.07 recorded in 2024.
  • The sharpest move saw Interest Coverage Ratio plummeted 282.9% in 2024, then surged 201.13% in 2025.
  • Year by year, Interest Coverage Ratio stood at 14.79 in 2022, then tumbled by 72.03% to 25.44 in 2023, then skyrocketed by 70.69% to 7.46 in 2024, then skyrocketed by 124.32% to 1.81 in 2025.
  • Business Quant data shows Interest Coverage Ratio for ARWR at 1.81 in Q4 2025, 2.03 in Q3 2025, and 6.79 in Q2 2025.